Mersana Therapeutics, Inc. (NASDAQ:MRSN) Financial Efficiency Analysis

Mersana Therapeutics, Inc. (NASDAQ:MRSN) is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) for cancer treatment. The company aims to improve the lives of patients with cancer by creating innovative therapies. Mersana operates in a competitive landscape alongside companies like Kura Oncology, MacroGenics, Syndax Pharmaceuticals, Deciphera Pharmaceuticals, and Scholar Rock Holding Corporation.In evaluating Mersana's financial efficiency, the Return on Invested ...